冠心病患者代谢指纹图谱:棕榈酸预测冠心病发病风险强大

2019-09-02 佚名 中国循环杂志

阜外医院窦克非、朱成刚、刘倩倩等应用超高效液相色谱—飞行时间质谱联用(UHPLC-QTOF/MS)的非靶向代谢组学方法获得了中国冠心病患者群体的代谢指纹图谱,发现了105个与冠心病相关的代谢物。

阜外医院窦克非、朱成刚、刘倩倩等应用超高效液相色谱—飞行时间质谱联用(UHPLC-QTOF/MS)的非靶向代谢组学方法获得了中国冠心病患者群体的代谢指纹图谱,发现了105个与冠心病相关的代谢物。

研究者经过多元线性回归分析及 Bonferroni 校正后,从 105 个两组间差异显着的代谢物中筛选出棕榈酸、亚油酸、脂酰肉毒碱(14:1)、石胆酸、磷脂酰甘油(20:3/2:0)等 5 种差异最为显着的血浆代谢物。

校正危险因素后,Logistic 回归模型分析结果显示,这 5 种代谢物与冠心病发病风险呈显着正相关(OR=2.791~7.237)。

其中,石胆酸和磷脂酰甘油(20:3/2:0),是首次挖掘出的与冠心病病理生理过程有强关联的潜在生物标志物,分别增加2.7~3.9倍冠心病风险。

棕榈酸,是上述5种代谢物中冠心病发病风险预测能力最高的代谢物(OR=7.237,95% CI:2.390~21.912,P=0.0001)。

有研究显示,棕榈酸(16:0)可以显着增加总胆固醇及低密度脂蛋白(LDL)水平;还有研究显示,棕榈酸可通过触发炎症相关通路诱发动脉粥样硬化形成。

其次,亚油酸也与冠心病发病风险显着相关,每升高1个单位,冠心病的患病风险就增加 6.133 倍(95% CI:2.367~15.893,P=0.0005)。

这项研究对 150 例严重冠状动脉狭窄(狭窄≥80%)的冠心病患者(冠心病组)和年龄与性别 1:1 匹配的 150 例冠状动脉造影正常(狭窄≤20%)者(对照组)进行血浆代谢组学分析。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1668633, encodeId=bf4716686337d, content=<a href='/topic/show?id=8ce6564391b' target=_blank style='color:#2F92EE;'>#指纹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56439, encryptionId=8ce6564391b, topicName=指纹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae126370631, createdName=gous, createdTime=Tue Apr 21 09:17:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377775, encodeId=e7ad3e77756d, content=冠状动脉疾病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 04 15:26:07 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373263, encodeId=8d9f3e32630f, content=冠心病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 27 17:28:37 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447756, encodeId=d021144e7561a, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Sep 04 12:17:00 CST 2019, time=2019-09-04, status=1, ipAttribution=)]
    2020-04-21 gous
  2. [GetPortalCommentsPageByObjectIdResponse(id=1668633, encodeId=bf4716686337d, content=<a href='/topic/show?id=8ce6564391b' target=_blank style='color:#2F92EE;'>#指纹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56439, encryptionId=8ce6564391b, topicName=指纹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae126370631, createdName=gous, createdTime=Tue Apr 21 09:17:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377775, encodeId=e7ad3e77756d, content=冠状动脉疾病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 04 15:26:07 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373263, encodeId=8d9f3e32630f, content=冠心病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 27 17:28:37 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447756, encodeId=d021144e7561a, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Sep 04 12:17:00 CST 2019, time=2019-09-04, status=1, ipAttribution=)]
    2020-01-04 jyzxjiangqin

    冠状动脉疾病的治疗。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1668633, encodeId=bf4716686337d, content=<a href='/topic/show?id=8ce6564391b' target=_blank style='color:#2F92EE;'>#指纹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56439, encryptionId=8ce6564391b, topicName=指纹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae126370631, createdName=gous, createdTime=Tue Apr 21 09:17:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377775, encodeId=e7ad3e77756d, content=冠状动脉疾病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 04 15:26:07 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373263, encodeId=8d9f3e32630f, content=冠心病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 27 17:28:37 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447756, encodeId=d021144e7561a, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Sep 04 12:17:00 CST 2019, time=2019-09-04, status=1, ipAttribution=)]
    2019-09-27 jyzxjiangqin

    冠心病的治疗。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1668633, encodeId=bf4716686337d, content=<a href='/topic/show?id=8ce6564391b' target=_blank style='color:#2F92EE;'>#指纹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56439, encryptionId=8ce6564391b, topicName=指纹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dae126370631, createdName=gous, createdTime=Tue Apr 21 09:17:00 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377775, encodeId=e7ad3e77756d, content=冠状动脉疾病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sat Jan 04 15:26:07 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373263, encodeId=8d9f3e32630f, content=冠心病的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Sep 27 17:28:37 CST 2019, time=2019-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447756, encodeId=d021144e7561a, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Sep 04 12:17:00 CST 2019, time=2019-09-04, status=1, ipAttribution=)]

相关资讯

阜外医院舒畅等研究称,对于主动脉病变同时合并冠心病患者,杂交手术疗效满意

主动脉病变合并冠心病很常见,其治疗方式包括分期手术和同期手术。具体到每一例患者如何选择治疗策略还需考虑个体化因素。

高血压伴冠心病,如何进行血压管理?

患者10年前无明显诱因下突然出现胸闷,稍感心慌,不伴明显胸痛,活动后明显,每次持续2分钟左右,休息或服药后缓解,不伴有恶心、呕吐、黑朦等症状,平素未予重视,发作时当地医院就诊服药后症状好转。近1月发作次数较前明显增多,每天1-2次,发作与活动无关,每次持续2分钟左右,休息后或服药后好转。

把心梗当感冒,医生从他心血管里抽出三根粗大血栓

人到中年最该认识的不是大人物,是心梗

Radiology:预测心血管事件:左室肥厚优于冠状动脉钙化评分

根据发表在《Radiology》杂志上的一项新研究,左心室质量升高,即左心室肥大,比冠状动脉钙化评分更能预测不良心血管事件。

老年患者肺内同时性多原发癌合并冠心病麻醉处理1例

患者,男,65岁,身高160 cm,体质量53kg。因咳嗽咳痰伴胸痛于2016年3月在云南省肿瘤医院诊断为右肺下叶癌,并行胸腔镜下右肺下叶癌根治术,术后6个月复查时发现左肺下叶基底段新发结节,肺部CT如图1所示。术前诊断:(1)右肺下叶癌根治术后;(2)左肺下叶基底段结节性质待查;(3)冠状动脉粥样硬化性心脏病可能。拟行电视辅助胸腔镜手术(video-assisted thoracic sur

山西学者:七成空腹血糖<7.0 mmol/L的冠心病患者糖代谢异常

众所周知,血糖高了对冠心病患者是雪上加霜,那么一个冠心病患者空腹血糖 <7.0 mmol/L就血糖安好吗? 山西西山煤电(集团)有限责任公司职工总医院陈焕梅等研究发现,空腹血糖 <7.0 mmol/L的冠心病患者中七成糖代谢异常,而且冠脉多支病变患者较冠脉单支病变患者存在更多的糖代谢异常。